Smithkline Beecham (private) Ltd, Pharmaceutical Import Profile — Sri Lanka (DGFT 2022–2026)

Name: Smithkline Beecham (private) Ltd, Pharmaceutical Import Records from India — 2 Products, $2.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Smithkline Beecham (private) Ltd, — Pharmaceutical Importer Profile (2026) | 2 Products, $2.8M Trade | TransData Nexus

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Paracetamol	Analgesics & Antipyretics	$2.8M	55	0.8%	6
2	Iodex	Brand Names & OTC Products	$15.7K	4	0.2%	8

Smithkline Beecham (private) Ltd, imports 2 pharmaceutical products across 2 categories into Sri Lanka totaling $2.8M.

Smithkline Beecham (private) Ltd, — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Smithkline Beecham (Private) Limited, established in 2008, is a prominent pharmaceutical importer and wholesaler based in Colombo, Sri Lanka. Operating from the World Trade Centre, Colombo 1, the company specializes in the distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. With a workforce of approximately 50 employees, Smithkline Beecham (Private) Limited reported an annual sales turnover of $5.43 million, reflecting its significant presence in the Sri Lankan pharmaceutical market.

As a subsidiary of the global pharmaceutical giant GlaxoSmithKline (GSK), Smithkline Beecham (Private) Limited plays a crucial role in the importation and distribution of GSK's pharmaceutical products within Sri Lanka. The company's operations are integral to GSK's strategy of ensuring the availability of its products in the Sri Lankan market, thereby contributing to the overall healthcare infrastructure of the country.

2Distribution Network

Smithkline Beecham (Private) Limited's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products across Sri Lanka. While specific warehouse locations are not publicly disclosed, the company's central office at the World Trade Centre in Colombo 1 serves as a pivotal hub for its operations. The logistics capabilities are tailored to handle a diverse range of pharmaceutical products, ensuring compliance with Sri Lankan regulations and maintaining product integrity throughout the supply chain.

The company's geographic coverage spans the entire island, facilitating timely and reliable distribution to various regions. This extensive reach underscores Smithkline Beecham (Private) Limited's commitment to meeting the pharmaceutical needs of the Sri Lankan population, ensuring that essential medications are accessible to both urban and rural communities.

3Industry Role

In Sri Lanka's pharmaceutical supply chain, Smithkline Beecham (Private) Limited functions primarily as a pharmaceutical importer and wholesaler. The company is responsible for sourcing finished pharmaceutical formulations from international markets, particularly India, and distributing them to various stakeholders within the country. This role is critical in bridging the gap between global pharmaceutical manufacturers and the local healthcare system, ensuring the availability of a wide range of medications to meet the diverse needs of the Sri Lankan population.

By importing and wholesaling pharmaceutical products, Smithkline Beecham (Private) Limited ensures that essential medications are accessible to healthcare providers, pharmacies, and ultimately, patients across Sri Lanka. This function is vital in maintaining the stability and reliability of the pharmaceutical supply chain within the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Smithkline Beecham (private) Ltd,

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Smithkline Beecham (Private) Limited's sourcing strategy exhibits a high degree of concentration, with a significant portion of its pharmaceutical imports originating from India. This focused approach allows the company to leverage established relationships with Indian manufacturers, ensuring a consistent supply of quality products. The shipment data indicates a stable and ongoing relationship with Indian suppliers, as evidenced by the regularity and volume of imports over the past years.

While this concentrated sourcing strategy offers benefits such as streamlined logistics and potential cost efficiencies, it also presents risks associated with over-reliance on a single source. Any disruptions in the Indian pharmaceutical market—be it regulatory changes, supply chain issues, or geopolitical tensions—could impact Smithkline Beecham (Private) Limited's ability to meet domestic demand. Therefore, the company must continuously assess and manage these risks to maintain a resilient supply chain.

2Supply Chain Resilience

The resilience of Smithkline Beecham (Private) Limited's supply chain is closely tied to its sourcing strategy from India. The company's reliance on a single supplier base necessitates robust contingency planning to mitigate potential disruptions. While specific details regarding backup suppliers and formulation diversity are not publicly available, the company's established presence in the Sri Lankan market suggests proactive measures to ensure continuity of supply.

Importing Pharmaceuticals into Sri Lanka — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Sri Lanka

1Regulatory Authority & Framework

The National Medicines Regulatory Authority (NMRA) is the primary regulatory body overseeing pharmaceutical imports in Sri Lanka. Operating under the Ministry of Health, the NMRA is responsible for ensuring the safety, efficacy, and quality of medicines entering the Sri Lankan market. The NMRA's mandate includes the registration of pharmaceutical products, issuance of import licenses, and enforcement of compliance with national health standards. (nmra.gov.lk)

Key legislation governing pharmaceutical imports includes the Medicines (Pricing Mechanism for Medicines) Regulations, which establish guidelines for the pricing of imported medicines to ensure affordability and accessibility for the Sri Lankan population. Additionally, the NMRA has introduced guidelines on import control, specifying procedures for the importation, storage, and distribution of pharmaceutical products to maintain public health standards. (nmra.gov.lk)

2Import Licensing & GMP

Import licensing is a critical component of Sri Lanka's pharmaceutical regulatory framework. All pharmaceutical products intended for importation must be registered with the NMRA and receive approval before distribution or sale. Import license applications should be submitted at least twelve weeks in advance to avoid delays. As of February 2026, the NMRA requires price submissions for import licenses that expire on or after 1st February 2026.

Smithkline Beecham (private) Ltd, — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Smithkline Beecham (Private) Limited's product strategy focuses on importing and distributing finished pharmaceutical formulations, particularly in the analgesics and antipyretics therapeutic category. The company's import data indicates a significant volume of paracetamol products, highlighting the market demand for pain relief and fever-reducing medications in Sri Lanka. This focus aligns with the prevalent health concerns and the need for accessible over-the-counter pain management solutions.

The importation of brand-name and over-the-counter (OTC) products, such as Iodex, reflects a strategic approach to cater to consumer preferences for trusted and widely recognized brands. By offering these products, Smithkline Beecham (Private) Limited aims to meet the demand for effective and reliable pharmaceutical solutions in the Sri Lankan market.

2Sourcing Profile

Smithkline Beecham (Private) Limited's sourcing strategy is centered on importing generic drug formulations from India, focusing on finished pharmaceutical products rather than active pharmaceutical ingredients (APIs) or bulk drugs. This

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Smithkline Beecham (private) Ltd,

What products does Smithkline Beecham (private) Ltd, import from India?

Smithkline Beecham (private) Ltd, imports 2 pharmaceutical products across 2 categories. Top imports: Paracetamol ($2.8M), Iodex ($15.7K).

What is Smithkline Beecham (private) Ltd,'s total pharmaceutical import value?

Smithkline Beecham (private) Ltd,'s total pharmaceutical import value from India is $2.8M, based on 59 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Smithkline Beecham (private) Ltd, focus on?

Smithkline Beecham (private) Ltd, imports across 2 categories. The largest: Analgesics & Antipyretics (99.4%), Brand Names & OTC Products (0.6%).

Get Full Smithkline Beecham (private) Ltd, Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Smithkline Beecham (private) Ltd,

Smithkline Beecham (private) Ltd, — Import Portfolio & Supplier Network

What Products Does Smithkline Beecham (private) Ltd, Import?

Top Products by Import Value

Smithkline Beecham (private) Ltd, Therapeutic Categories — 2 Specializations